These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16109620)

  • 1. Regression of pulmonary MALT lymphoma after treatment with rituximab.
    Chong EA; Svoboda J; Cherian S; Andreadis C; Downs LH; Zhuang H; Alavi A; Tsai DE; Schuster SJ
    Leuk Lymphoma; 2005 Sep; 46(9):1383-6. PubMed ID: 16109620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
    Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
    Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of localized oral MALT lymphoma by rituximab: a case report.
    Yamagata K; Onizawa K; Kojima H; Yoshida H
    Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
    Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
    Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
    Ohno H; Isoda K
    J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
    Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
    Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
    [No Abstract]   [Full Text] [Related]  

  • 7. Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
    Nakao M; Oguri T; Maeno K; Kusumoto S; Ota C; Takakuwa O; Uemura T; Ozasa H; Iwashima Y; Miyazaki M; Kutsuna T; Nakamura A; Inagaki H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1711-4. PubMed ID: 19838033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
    Wu Y; Zhao L; Chai Y
    Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
    Woehrer S; Streubel B; Chott A; Hoffmann M; Raderer M
    Leuk Lymphoma; 2005 Nov; 46(11):1645-9. PubMed ID: 16236618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line 90Yttrium-ibritumomab tiuxetan (Zevalin) in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma refractory to rituximab.
    Oellers P; Savar A; Samaniego F; Pro B; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2012; 28(6):e145-6. PubMed ID: 22820440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary MALT lymphoma revealing AIDS].
    Cortot AB; Cottin V; Issartel B; Meyronet D; Coiffier B; Cordier JF
    Rev Mal Respir; 2006 Sep; 23(4 Pt 1):353-7. PubMed ID: 17127912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.
    Arndt S; Veelken H; Schmitt-Gräff A; Aschendorff A; Maier W; Richter B
    Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):257-61. PubMed ID: 17491523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
    Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
    Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma.
    Lantuejoul S; Moulai N; Quetant S; Brichon PY; Brambilla C; Brambilla E; Ferretti GR
    Eur Respir J; 2007 Sep; 30(3):589-92. PubMed ID: 17766635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab-induced remission of a gastric MALT lymphoma.
    Datta YH; Kampalath B; Binion DG
    Leuk Lymphoma; 2004 Jun; 45(6):1297-9. PubMed ID: 15360017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].
    Kagawa M; Okamura S; Okamoto K; Kitamura S; Kimura T; Niki M; Kaji M; Okahisa T; Yano M; Kagawa S; Kudo E; Sano T; Imoto Y; Wada S; Takayama T
    Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):612-9. PubMed ID: 20379095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.
    Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K
    Leuk Lymphoma; 2013 Sep; 54(9):1928-33. PubMed ID: 23216271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma.
    Hoffmann M; Troch M; Eidherr H; Traub-Weidinger T; Jonak C; Muellauer L; Raderer M
    Leuk Lymphoma; 2011 Jan; 52(1):42-5. PubMed ID: 21133720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
    Arkenau HT; Gordon C; Cunningham D; Norman A; Wotherspoon A; Chau I
    Leuk Lymphoma; 2007 Mar; 48(3):547-50. PubMed ID: 17454597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.